Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-015445
Filing Date
2024-02-21
Accepted
2024-02-20 18:36:14
Documents
85
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0200196-10q_cambell.htm   iXBRL 10-Q 711733
2 CERTIFICATION ea0200196ex31-1_cambell.htm EX-31.1 8070
3 CERTIFICATION ea0200196ex32-1_cambell.htm EX-32.1 3766
4 GRAPHIC image_001.jpg GRAPHIC 26287
5 GRAPHIC image_002.jpg GRAPHIC 100710
6 GRAPHIC image_003.jpg GRAPHIC 14497
7 GRAPHIC image_004.jpg GRAPHIC 13585
8 GRAPHIC image_005.jpg GRAPHIC 9127
  Complete submission text file 0001213900-24-015445.txt   5243408

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE bimt-20231231.xsd EX-101.SCH 61464
10 XBRL CALCULATION FILE bimt-20231231_cal.xml EX-101.CAL 42338
11 XBRL DEFINITION FILE bimt-20231231_def.xml EX-101.DEF 235633
12 XBRL LABEL FILE bimt-20231231_lab.xml EX-101.LAB 428865
13 XBRL PRESENTATION FILE bimt-20231231_pre.xml EX-101.PRE 246576
87 EXTRACTED XBRL INSTANCE DOCUMENT ea0200196-10q_cambell_htm.xml XML 607783
Mailing Address UNIT NO. 5784 152 CHARTERED SQUARE BUILDING, 212/19 BANGKOK W1 10500
Business Address UNIT NO. 5784 152 CHARTERED SQUARE BUILDING, 212/19 BANGKOK W1 10500 7026050123
CAMBELL INTERNATIONAL HOLDING CORP. (Filer) CIK: 0001678848 (see all company filings)

EIN.: 981310024 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-214469 | Film No.: 24655596
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)